DNA vaccine Wistar Institute/Inovio Pharmaceuticals/Public Health Agency of Canada/University of Pennsylvania/University of Manitoba

N/A

Report date: 2025/03/18 20:00:05

Base Information

Drug NameDNA vaccine Wistar Institute/Inovio Pharmaceuticals/Public Health Agency of Canada/University of Pennsylvania/University of Manitoba
Drug Alias NameEBOV-GP DNA vaccine
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanadaUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesThe Wistar Institute Of Anatomy And Biology
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesInovio Pharmaceuticals IncUniversity Of ManitobaThe Wistar Institute Of Anatomy And Biology +[5] 
Active IndicationsN/A
Inactive IndicationsHemorrhagic Fever, Ebola

Other Information

ATC CodeN/A
Related LinksN/A